BBLG

Bone Biologics Corporation [BBLG] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BBLG Stock Summary

Top 10 Correlated ETFs

BBLG


Top 10 Correlated Stocks

BBLG


In the News

08:37 26 Feb 2024 BBLG

Why Is Bone Biologics (BBLG) Stock Down 38% Today?

Bone Biologics (NASDAQ: BBLG ) stock is falling on Friday after the medical device company's shares underwent a major rally the day prior. That rally was caused by heavy trading of BBLG stock.

07:46 26 Feb 2024 BBLG

Why Is Bone Biologics (BBLG) Stock Up 84% Today?

Bone Biologics (NASDAQ: BBLG ) stock is rocketing higher despite a lack of news from the medical device company on Thursday. There are no new press releases or filings with the Securities and Exchange Commission that explain why BBLG stock is up today.

03:06 26 Feb 2024 BBLG

Penny Stocks to Watch: Why Is ELOX Stock Skyrocketing?

Most traders dream of hitting it big, and penny stocks are some of the most attractive for day traders. It can be any given session where we see at least a handful of cheap stocks under $5 explode.

07:49 26 Feb 2024 BBLG

Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month - Bone Biologics (NASDAQ:BBLG), Fresh2 Group (NASDAQ:FRES)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

09:22 26 Feb 2024 BBLG

Bone Biologics stock plummets more than 50% after stock offering prices at deep discount

Shares of Bone Biologics Corp. BBLG plummeted 51.9% toward a record low in premarket trading Thursday, after the developer of regenerative medicine for bones announced the pricing of its relatively large stock offering at a deep discount. The company raised $5 million, as it said overnight that it sold 2.54 million shares, which represented 15.2% of the shares outstanding, at price of $1.97 per share.

08:40 26 Feb 2024 BBLG

Why Is Bone Biologics (BBLG) Stock Down 52% Today?

Bone Biologics (NASDAQ: BBLG ) stock is breaking down on Thursday after the company announced the details of a public share offering. Bone Biologics has revealed its public offering prices shares of BBLG stock at $1.97 each.

11:51 26 Feb 2024 BBLG

Penny Stocks To Buy Now? 10 Stocks Under $1 To Watch

Penny stocks to watch trading under $1 right now. The post Penny Stocks To Buy Now?

02:51 26 Feb 2024 BBLG

7 Hot Penny Stocks Under $1 To Watch This Week

Penny stocks to watch trading under $1 right now. The post 7 Hot Penny Stocks Under $1 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

01:54 26 Feb 2024 BBLG

Best Penny Stocks To Buy? 4 Biotech Stocks To Watch Right Now

Biotech penny stocks to watch right now. The post Best Penny Stocks To Buy?

03:50 26 Feb 2024 BBLG

BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today

Today, investors in Bone Biologics and BBLG stock are seeing some serious gains as investors dive into niche small caps. The post BBLG Stock Alert: 7 Things to Know as Bone Biologics Skyrockets Today appeared first on InvestorPlace.

BBLG Financial details

Company Rating
Neutral
Market Cap
1.92M
Income
-4.89M
Revenue
0
Book val./share
1.21
Cash/share
1.42
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
18 Mar 2024
P/E
-3.03
Forward P/E
-0.32
PEG
0.1
P/S
-
P/B
3.91
P/C
2.54
P/FCF
-0.27
Quick Ratio
3.76
Current Ratio
4.21
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.95
EPS next Y
-11.09
EPS next Q
1.58
EPS this Y
-1958.47%
EPS next Y
180.76%
EPS next 5Y
180.76%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-63.91%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.07%
Inst Trans
0%
ROA
-98%
ROE
-107%
ROC
-2.52%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
534.24K
Shs Float
532.09K
-
-
-
-
Target Price
-
52W Range
2.86-86.88
52W High
-95.81%
52W Low
+80%
RSI
100
Rel Volume
0.1
Avg Volume
231.89K
Volume
22.31K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.66
-
-
Volatility
1.26%, 0.65%
Prev Close
-
Price
3.6
Change
-

BBLG Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-66.12-35.23-18.8-10.641.83
Operating cash flow per share
-61.26-33.45-4.4-8.12-9.37
Free cash flow per share
-61.26-33.45-4.4-8.12-9.37
Cash per share
14.260.25044.0919.8
Book value per share
-128.31-122.08-141.0943.4315.62
Tangible book value per share
-128.31-122.08-141.0943.4315.62
Share holders equity per share
-128.31-122.08-141.0943.4315.62
Interest debt per share
152.66106.41131.085.32-5.73
Market cap
81.86M118.75M118.55M127.9M19.19M
Enterprise value
89.9M130.05M130.27M121.22M11.65M
P/E ratio
-18.48-34.67-64.97-79.4127.58
Price to sales ratio
00000
POCF ratio
-19.94-36.52-277.68-104.1-5.38
PFCF ratio
-19.94-36.52-277.68-104.1-5.38
P/B Ratio
-9.52-10.01-8.6619.453.23
PTB ratio
-9.52-10.01-8.6619.453.23
EV to sales
00000
Enterprise value over EBITDA
-37.73-53.14-157.9-110.06-2.65
EV to operating cash flow
-21.9-40-305.13-98.67-3.27
EV to free cash flow
-21.9-40-305.13-98.67-3.27
Earnings yield
-0.05-0.03-0.02-0.010.04
Free cash flow yield
-0.05-0.030-0.01-0.19
Debt to equity
-1.05-0.95-0.8600
Debt to assets
8.65367.21000
Net debt to EBITDA
-3.38-4.62-14.216.061.71
Current ratio
0.110.05066.813.33
Interest coverage
-2.272.51-0.83-1.371.68
Income quality
0.930.950.230.762.4
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
436.9311.09244.32101.9625.34
ROIC
-6.954.470.42-0.170.29
Return on tangible assets
-4.26-111.10-0.240.08
Graham Net
-129.59-122.15-141.0943.4313.11
Working capital
-8.6M-547.62K-13.69M6.58M5.95M
Tangible asset value
-8.6M-11.87M-13.69M6.58M5.95M
Net current asset value
-8.6M-11.87M-13.69M6.58M5.95M
Invested capital
-1.05-0.95-0.8600
Average receivables
00000
Average payables
171.05K84.04K254.14K282.65K50.4K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
0.520.290.13-0.240.12
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-3.536.3-7.95-1.69-0.61
Operating cash flow per share
-1.15-4-2.51-3.47-0.82
Free cash flow per share
-1.15-4-2.51-3.47-0.82
Cash per share
14.6615.4511.526.691.42
Book value per share
12.7612.195.165.441.21
Tangible book value per share
12.7612.195.165.441.21
Share holders equity per share
12.7612.195.165.441.21
Interest debt per share
0-4.471.0500
Market cap
86.94M24.6M33.39M11.98M17.8M
Enterprise value
81.89M17.06M27.2M4.97M13.35M
P/E ratio
-17.832-1.95-1.69-2.32
Price to sales ratio
00000
POCF ratio
-219.96-12.61-24.73-3.3-6.97
PFCF ratio
-219.96-12.61-24.73-3.3-6.97
P/B Ratio
19.754.1412.042.14.69
PTB ratio
19.754.1412.042.14.69
EV to sales
00000
Enterprise value over EBITDA
-67.1619.13-10.52-1.15-6.42
EV to operating cash flow
-207.16-8.74-20.15-1.37-5.22
EV to free cash flow
-207.16-8.74-20.15-1.37-5.22
Earnings yield
-0.010.12-0.13-0.15-0.11
Free cash flow yield
0-0.08-0.04-0.3-0.14
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
4.15-8.452.391.632.14
Current ratio
6.513.331.693.954.21
Interest coverage
00.59-5.600
Income quality
0.32-2.180.362.051.33
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
31.8541.5530.3914.384.08
ROIC
-0.28-0.75-1.31-0.53-0.55
Return on tangible assets
-0.230.36-0.63-0.23-0.39
Graham Net
12.3510.234.054.851.04
Working capital
4.4M5.95M2.77M5.69M3.79M
Tangible asset value
4.4M5.95M2.77M5.69M3.79M
Net current asset value
4.4M5.95M2.77M5.69M3.79M
Invested capital
00000
Average receivables
00000
Average payables
435.06K843.97K444.23K00
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
-0.280.52-1.54-0.31-0.51
Capex per share
00000

BBLG Frequently Asked Questions

What is Bone Biologics Corporation stock symbol ?

Bone Biologics Corporation is a US stock , located in Burlington of Ma and trading under the symbol BBLG

What is Bone Biologics Corporation stock quote today ?

Bone Biologics Corporation stock price is $3.6 today.

Is Bone Biologics Corporation stock public?

Yes, Bone Biologics Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap